Results 211 to 220 of about 116,751 (358)

Cancer and Placebos [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 1981
openaire   +2 more sources

Optimizing Peripheral Nerve Block Placement in Hip Surgery: A Cadaveric Study Mapping the Posterior Cutaneous Innervation

open access: yesClinical Anatomy, EarlyView.
ABSTRACT Optimizing analgesia after hip surgery enables more rapid recovery. However, peripheral nerve blocks (PNBs) often fail to provide adequate pain relief in the posterolateral hip as they typically target the lateral cutaneous nerve of the thigh (LCNT).
Ziki Gurney   +5 more
wiley   +1 more source

Placebo and placebo effects in medicine [PDF]

open access: yesJournal of the Royal Society of Medicine, 2000
Michael Emmans Dean, Joseph S Conway
openaire   +2 more sources

An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial

open access: yesCancer Communications, EarlyView.
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang   +18 more
wiley   +1 more source

Sobre placebo e efeito placebo [PDF]

open access: yesRevista Latinoamericana de Psicopatologia Fundamental, 2002
Mônica Teixeira   +1 more
openaire   +2 more sources

Conditioned open-label placebos to facilitate opioid reduction in patients with chronic non-cancer pain: study protocol of a randomised controlled trial. [PDF]

open access: yesBMJ Open
Carratta K   +13 more
europepmc   +1 more source

Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: Restoration of previously unpublished methodology [PDF]

open access: yes, 2020
Bourgeois, Florence   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy